Quantifying benefit and harm of extracorporeal life support in cardiogenic shock complicating acute myocardial infarction-Reference-Cited by-同舟云学术

Quantifying benefit and harm of extracorporeal life support in cardiogenic shock complicating acute myocardial infarction

Published:2024-08-28 Issue: Volume: Page:
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Jung Christian^ORCID,Wernly Bernhard,Kelm Malte,Zeymer Uwe,Thiele Holger, ,Bruno Raphael,Freund Anne,Pöss Janine,Desch Steffen,Schneider Steffen,Akin Ibrahim,Schupp Tobias,Pöss Janine,Rassaf Tienush,Lehmann Ralf,Eitel Ingo,Skurk Carsten,Clemmensen Peter,Hennersdorf Marcus,Voigt Ingo,Linke Axel,Tigges Eike,Nordbeck Peter,Bruno Raphael,Lauten Philipp,Feistritzer Hans-Josef,Buske Maria,Schneider Steffen,Duerschmied Daniel,Desch Steffen,Freund Anne,Akin Ibrahim

Funder

Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00134-024-07607-0.pdf

Reference5 articles.

1. Thiele H, Akin I, Sandri M et al (2018) One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med 379:1699–1710

2. Ughetto A, Schrage B, Delmas C (2024) Cardiogenic shock in 2024: insight the complex reality of ECLS and left ventricular unloading strategies. Intensive Care Med. https://doi.org/10.1007/s00134-024-07400-z

3. Thiele H, Zeymer U, Akin I et al (2023) Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med 389:1286–1297

4. Granholm A, Alhazzani W, Derde LPG et al (2022) Randomised clinical trials in critical care: past, present and future. Intensive Care Med 48:164–178

5. Wijeysundera DN, Austin PC, Hux JE et al (2009) Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiol 62:13-21.e5